[123I]β-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls

European Journal of Nuclear Medicine

Volumn 24, Issue 9, 1997, Pages 1171-1174

  Tissingh, G ^a   Bergmans, P ^a   Booij, J ^b   Winogrodzka, A ^a   Stoof, J C ^a   Wolters, E C ^a   Van Royen, E A ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Aging; Dopamine transporter imaging; Parkinson's disease; Single photon emission tomography

Indexed keywords

BRAIN RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; IODINE 123; TRACER; TROPANE DERIVATIVE; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CARRIER PROTEIN; COCAINE; DIAGNOSTIC AGENT; DOPAMINE; DRUG DERIVATIVE; MEMBRANE PROTEIN; NERVE PROTEIN; RADIOACTIVE IODINE;

ADULT; AGED; AGING; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; DETERIORATION; DISEASE SEVERITY; DOPAMINE BRAIN LEVEL; HUMAN; IN VIVO STUDY; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; RECEPTOR BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; STRIATE CORTEX; BRAIN; CORPUS STRIATUM; FEMALE; MALE; METABOLISM; MIDDLE AGED; SCINTISCANNING;

ADULT; AGED; AGING; BRAIN; CARRIER PROTEINS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 85047680884     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01254252     Document Type: Article

References (13)

1. 3H]GBR-12935 in human putamen. Neurobiol Aging 1989; 10: 661-664.
2. Keyser De JD, Ebinger G, Vauquelin T. Age-related changes in the human nigrostriatal dopaminergic systemin. Ann Neurol 1990; 27: 157-161.
3. Zelnik N, Angel I, Paul SM, Kleinman JE. Decreased density of human striatal dopamine uptake sites with age. Eur J Pharmacol 1986; 126: 175-176.
4. Innis RB, Seibyl JP, Scanley BE, et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proc Natl Acad Sci USA 1993; 90: 11965-11969.
5. Van Dyck CH, Seibyl JP, Malison RT, et al. Age-related decline in striatal dopamine transporter binding with iodine-123-β-CIT SPECT. J Nucl Med 1995; 36: 1175-1181.
6. 11C-nomifensine and positron emission tomography: the effects of age and Parkinson's disease. Acta Neurol Scand 1988; 77: 192-201.
7. 123I]β-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology 1996; 46: 231-237.
8. 123I]FP-CIT SPECT in the demonstration of the dopaminergic deficit in Parkinson's disease. Eur J Nucl Med 1997; 24: 68-71.
9. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-2301.
10. Volkow ND, Fowler JS, Wang GJ, et al. Decreased dopamine transporters with age in healthy human subjects. Ann Neurol 1994; 36: 237-239.
11. Volkow ND, Ding Y-S, Fowler JS, et al. Dopamine transporters decrease with age. J Nucl Med 1996; 37: 554-559.
12. Ishikawa T, Dhawan V, Kazumata K, et al. Comparative nigrostriatal dopaminergic imaging with iodine-123-βCIT-FP/SPECT and fluorine-18-FDOPA/PET. J Nucl Med 1996; 37: 1760-1765.
13. Mozley PD, Kim H-J, Gur RC, et al. Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values. J Nucl Med 1996; 37: 1965-1970.